184 related articles for article (PubMed ID: 21079728)
1. Inhibition of glioblastoma growth by the thiadiazolidinone compound TDZD-8.
Aguilar-Morante D; Morales-Garcia JA; Sanz-SanCristobal M; Garcia-Cabezas MA; Santos A; Perez-Castillo A
PLoS One; 2010 Nov; 5(11):e13879. PubMed ID: 21079728
[TBL] [Abstract][Full Text] [Related]
2. Treatment with the glycogen synthase kinase-3beta inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus.
Collino M; Thiemermann C; Mastrocola R; Gallicchio M; Benetti E; Miglio G; Castiglia S; Danni O; Murch O; Dianzani C; Aragno M; Fantozzi R
Shock; 2008 Sep; 30(3):299-307. PubMed ID: 18323734
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3beta inhibition attenuates asthma in mice.
Bao Z; Lim S; Liao W; Lin Y; Thiemermann C; Leung BP; Wong WS
Am J Respir Crit Care Med; 2007 Sep; 176(5):431-8. PubMed ID: 17556716
[TBL] [Abstract][Full Text] [Related]
4. Fine-tuning of NFκB by glycogen synthase kinase 3β directs the fate of glomerular podocytes upon injury.
Bao H; Ge Y; Peng A; Gong R
Kidney Int; 2015 Jun; 87(6):1176-90. PubMed ID: 25629551
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of the new thiadiazolidinone NP00111 against oxygen-glucose deprivation in rat hippocampal slices: implication of ERK1/2 and PPARgamma receptors.
Rosa AO; Egea J; Martínez A; García AG; López MG
Exp Neurol; 2008 Jul; 212(1):93-9. PubMed ID: 18471812
[TBL] [Abstract][Full Text] [Related]
6. The role of glycogen synthase kinase-3β in glioma cell apoptosis induced by remifentanil.
Xu J; Xu P; Li Z; Xiao L; Yang Z
Cell Mol Biol Lett; 2013 Dec; 18(4):494-506. PubMed ID: 23990403
[TBL] [Abstract][Full Text] [Related]
7. Non-ATP competitive glycogen synthase kinase 3beta (GSK-3beta) inhibitors: study of structural requirements for thiadiazolidinone derivatives.
Castro A; Encinas A; Gil C; Bräse S; Porcal W; Pérez C; Moreno FJ; Martínez A
Bioorg Med Chem; 2008 Jan; 16(1):495-510. PubMed ID: 17919914
[TBL] [Abstract][Full Text] [Related]
8. TDZD-8 alleviates delayed neurological sequelae following acute carbon monoxide poisoning involving tau protein phosphorylation.
Su C; Zhao N; Zou J; Yan X
Inhal Toxicol; 2020 Feb; 32(2):79-85. PubMed ID: 32188325
[No Abstract] [Full Text] [Related]
9. Effects of glycogen synthase kinase-3beta inhibition on the development of cerulein-induced acute pancreatitis in mice.
Cuzzocrea S; Malleo G; Genovese T; Mazzon E; Esposito E; Muià C; Abdelrahman M; Di Paola R; Thiemermann C
Crit Care Med; 2007 Dec; 35(12):2811-21. PubMed ID: 18074481
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apoptosis.
Gao HK; Yin Z; Zhou N; Feng XY; Gao F; Wang HC
J Cardiovasc Pharmacol; 2008 Sep; 52(3):286-92. PubMed ID: 18806610
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte.
Kim SD; Yang SI; Kim HC; Shin CY; Ko KH
Brain Res; 2007 Dec; 1186():12-20. PubMed ID: 17996850
[TBL] [Abstract][Full Text] [Related]
12. Activation of AKT/GSK3β pathway by TDZD-8 attenuates kainic acid induced neurodegeneration but not seizures in mice.
Bhowmik M; Khanam R; Saini N; Vohora D
Neurotoxicology; 2015 Jan; 46():44-52. PubMed ID: 25453207
[TBL] [Abstract][Full Text] [Related]
13. Growth control of multiple myeloma cells through inhibition of glycogen synthase kinase-3.
Zhou Y; Uddin S; Zimmerman T; Kang JA; Ulaszek J; Wickrema A
Leuk Lymphoma; 2008 Oct; 49(10):1945-53. PubMed ID: 18728964
[TBL] [Abstract][Full Text] [Related]
14. Diabetes Worsens Ischemia-Reperfusion Brain Injury in Rats Through GSK-3β.
Liu H; Ou S; Xiao X; Zhu Y; Zhou S
Am J Med Sci; 2015 Sep; 350(3):204-11. PubMed ID: 26226547
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of glycogen synthase kinase-3β attenuates organ injury and dysfunction associated with liver ischemia-reperfusion and thermal injury in the rat.
Rocha J; Figueira ME; Barateiro A; Fernandes A; Brites D; Pinto R; Freitas M; Fernandes E; Mota-Filipe H; Sepodes B
Shock; 2015 Apr; 43(4):369-78. PubMed ID: 25394244
[TBL] [Abstract][Full Text] [Related]
16. GSK-3β inhibitor TDZD-8 reduces neonatal hypoxic-ischemic brain injury in mice.
Huang S; Wang H; Turlova E; Abussaud A; Ji X; Britto LR; Miller SP; Martinez A; Sun HS; Feng ZP
CNS Neurosci Ther; 2017 May; 23(5):405-415. PubMed ID: 28256059
[TBL] [Abstract][Full Text] [Related]
17. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
[TBL] [Abstract][Full Text] [Related]
18. GSK-3beta inhibitor modulates TLR2/NF-kappaB signaling following myocardial ischemia-reperfusion.
Gao HK; Yin Z; Zhang RQ; Zhang J; Gao F; Wang HC
Inflamm Res; 2009 Jul; 58(7):377-83. PubMed ID: 19274437
[TBL] [Abstract][Full Text] [Related]
19. Lupus nephritis: glycogen synthase kinase 3β promotion of renal damage through activation of the NLRP3 inflammasome in lupus-prone mice.
Zhao J; Wang H; Huang Y; Zhang H; Wang S; Gaskin F; Yang N; Fu SM
Arthritis Rheumatol; 2015 Apr; 67(4):1036-44. PubMed ID: 25512114
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.
Tang QL; Xie XB; Wang J; Chen Q; Han AJ; Zou CY; Yin JQ; Liu DW; Liang Y; Zhao ZQ; Yong BC; Zhang RH; Feng QS; Deng WG; Zhu XF; Zhou BP; Zeng YX; Shen JN; Kang T
J Natl Cancer Inst; 2012 May; 104(10):749-63. PubMed ID: 22534782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
